Proactive Investors - Run By Investors For Investors

Pfizer cuts losses on Brazil drug maker with sale for nominal sum

Generic drug makers in the country have struggled due to rising raw material costs and a prolonged recession.
picture of pills
Pfizer reportedly received just one real for its stake

Pharma giant Pfizer Inc (NYSE:PFE) has bitten the bullet on its Brazil generic drug making business after failing to find a buyer for its 40% stake.

According to Reuters, Pfizer has received just one real (30c) for the stake in Laboratório Teuto Brasileiro it paid US$240mln for seven years ago.

In a statement, Pfizer confirmed the transfer "after careful consideration," but said the terms of the deal were confidential.

Teuto is negotiating the refinancing of r600mln (US$180mln) in loans according to the report.

The Melos family were Pfizer’s partner in the venture but relations soured when the US firm was pressured into buying out their interest.

Goldman Sachs was among the banks appointed to find a buyer but its lack of success sparked renewed tensions within the venture.

Generic drug makers in the country have struggled due to rising raw material costs and a prolonged recession.

View full PFE profile View Profile

Pfizer Timeline

Article
November 23 2015

Related Articles

porcupine
November 30 2018
It’s been a tricky period for Redx, but it has come through it with a promising pipeline, cash in the bank and AstraZeneca’s former UK boss as its new chief executive
Collagen testing
August 17 2018
Since reporting its full-year results on July 10, the AIM-listed shares have rallied over 38% in the past month to 3.65p currently, taking year-to-date gains to a third
pippette
November 23 2018
The Australian regenerative medicine company is developing a portfolio of innovative cellular therapies targeting significant unmet medical needs with a licence-driven strategy.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use